Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $9.69 | Prev. Close $9.39 | Circuit Range N/A |
Day Range $9.65 - $10.25 | Year Range $1.28 - $16.34 | Volume 5,030 |
Average Traded $9.98 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $9.69 | $9.92 | +0.00% |
30-Apr-26 | $9.69 | $9.92 | +3.06% |
28-Apr-26 | $11.75 | $9.63 | -12.66% |
27-Apr-26 | $12.43 | $11.02 | -16.26% |
24-Apr-26 | $13.25 | $13.16 | -3.77% |
23-Apr-26 | $13.68 | $13.68 | +0.37% |
22-Apr-26 | $14.51 | $13.63 | -7.00% |